Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Erratum (v93,p2753)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kashiwagi, H.
Right arrow Articles by Shattil, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kashiwagi, H.
Right arrow Articles by Shattil, S. J.
Related Collections
Right arrow Hematopoiesis and Stem Cells
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, Vol. 93 No. 8 (April 15), 1999: pp. 2559-2568

A Mutation in the Extracellular Cysteine-Rich Repeat Region of the beta 3 Subunit Activates Integrins &b.alpha;IIbbeta 3 and &b.alpha;Vbeta 3

Hirokazu Kashiwagi, Yoshiaki Tomiyama, Seiji Tadokoro, Shigenori Honda, Masamichi Shiraga, Hajime Mizutani, Makoto Handa, Yoshiyuki Kurata, Yuji Matsuzawa, and Sanford J. Shattil

From The Second Department of Internal Medicine, Osaka University Medical School, and Department of Transfusion, Osaka University Hospital, Osaka, Japan; the Blood Center, Keio University Hospital, Tokyo, Japan; and the Department of Vascular Biology and Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA.

Inside-out signaling regulates the ligand-binding function of integrins through changes in receptor affinity and/or avidity. For example, alpha IIbbeta 3 is in a low-affinity/avidity state in resting platelets, and activation of the receptor by platelet agonists enables fibrinogen to bind. In addition, certain mutations and truncations of the integrin cytoplasmic tails are associated with a high-affinity/avidity receptor. To further evaluate the structural basis of integrin activation, stable Chinese hamster ovary (CHO) cell transfectants were screened for high-affinity/avidity variants of alpha IIbbeta 3. One clone (AM-1) expressed constitutively active alpha IIbbeta 3, as evidenced by (1) binding of soluble fibrinogen and PAC1, a ligand-mimetic antialpha IIbbeta 3 antibody; and (2) fibrinogen-dependent cell aggregation. Sequence analysis and mutant expression in 293 cells proved that a single amino acid substitution in the cysteine-rich, extracellular portion of beta 3(T562N) was responsible for receptor activation. In fact, T562N also activated alpha Vbeta 3, leading to spontaneous binding of soluble fibrinogen to 293 cells. In contrast, neither T562A nor T562Q activated alpha IIbbeta 3, suggesting that acquisition of asparagine at residue 562 was the relevant variable. T562N also led to aberrant glycosylation of beta 3, but this was not responsible for the receptor activation. The binding of soluble fibrinogen to alpha IIbbeta 3(T562N) was not sufficient to trigger tyrosine phosphorylation of pp125FAK, indicating that additional post-ligand binding events are required to activate this protein tyrosine kinase during integrin signaling. These studies have uncovered a novel gain-of-function mutation in a region of beta 3 intermediate between the ligand-binding region and the cytoplasmic tail, and they suggest that this region is involved in integrin structural changes during inside-out signaling.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
K. Vanhoorelbeke, S. F. De Meyer, I. Pareyn, C. Melchior, S. Plancon, C. Margue, O. Pradier, P. Fondu, N. Kieffer, T. A. Springer, et al.
The Novel S527F Mutation in the Integrin {beta}3 Chain Induces a High Affinity {alpha}IIb{beta}3 Receptor by Hindering Adoption of the Bent Conformation
J. Biol. Chem., May 29, 2009; 284(22): 14914 - 14920.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Salsmann, E. Schaffner-Reckinger, F. Kabile, S. Plancon, and N. Kieffer
A New Functional Role of the Fibrinogen RGD Motif as the Molecular Switch That Selectively Triggers Integrin {alpha}IIb{beta}3-dependent RhoA Activation during Cell Spreading
J. Biol. Chem., September 30, 2005; 280(39): 33610 - 33619.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Kashiwagi, M. Shiraga, H. Kato, T. Kamae, N. Yamamoto, S. Tadokoro, Y. Kurata, Y. Tomiyama, and Y. Kanakura
Negative regulation of platelet function by a secreted cell repulsive protein, semaphorin 3A
Blood, August 1, 2005; 106(3): 913 - 921.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
J. J. Calvete
Structures of Integrin Domains and Concerted Conformational Changes in the Bidirectional Signaling Mechanism of {alpha}IIb{beta}3
Experimental Biology and Medicine, September 1, 2004; 229(8): 732 - 744.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. Butta, E. G. Arias-Salgado, C. Gonzalez-Manchon, M. Ferrer, S. Larrucea, M. S. Ayuso, and R. Parrilla
Disruption of the {beta}3 663-687 disulfide bridge confers constitutive activity to {beta}3 integrins
Blood, October 1, 2003; 102(7): 2491 - 2497.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J.-P. Xiong, T. Stehle, S. L. Goodman, and M. A. Arnaout
New insights into the structural basis of integrin activation
Blood, August 15, 2003; 102(4): 1155 - 1159.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T.-T. Fujimoto, S. Katsutani, T. Shimomura, and K. Fujimura
Thrombospondin-bound Integrin-associated Protein (CD47) Physically and Functionally Modifies Integrin {alpha}IIb{beta}3 by Its Extracellular Domain
J. Biol. Chem., July 11, 2003; 278(29): 26655 - 26665.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Kiyoi, Y. Tomiyama, S. Honda, S. Tadokoro, M. Arai, H. Kashiwagi, S. Kosugi, H. Kato, Y. Kurata, and Y. Matsuzawa
A naturally occurring Tyr143Hisalpha IIb mutation abolishes alpha IIbbeta 3 function for soluble ligands but retains its ability for mediating cell adhesion and clot retraction: comparison with other mutations causing ligand-binding defects
Blood, May 1, 2003; 101(9): 3485 - 3491.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Buensuceso, M. de Virgilio, and S. J. Shattil
Detection of Integrin alpha IIbbeta 3 Clustering in Living Cells
J. Biol. Chem., April 18, 2003; 278(17): 15217 - 15224.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Q.-H. Sun, C.-Y. Liu, R. Wang, C. Paddock, and P. J. Newman
Disruption of the long-range GPIIIa Cys5-Cys435 disulfide bond results in the production of constitutively active GPIIb-IIIa (alpha IIbbeta 3) integrin complexes
Blood, August 28, 2002; 100(6): 2094 - 2101.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Santoso, V. Kiefel, I. G. Richter, U. J. H. Sachs, A. Rahman, B. Carl, and H. Kroll
A functional platelet fibrinogen receptor with a deletion in the cysteine-rich repeat region of the beta 3 integrin: the Oea alloantigen in neonatal alloimmune thrombocytopenia
Blood, February 15, 2002; 99(4): 1205 - 1214.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Tadokoro, Y. Tomiyama, S. Honda, H. Kashiwagi, S. Kosugi, M. Shiraga, T. Kiyoi, Y. Kurata, and Y. Matsuzawa
Missense mutations in the beta 3 subunit have a different impact on the expression and function between alpha IIbbeta 3 and alpha vbeta 3
Blood, February 1, 2002; 99(3): 931 - 938.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Ruiz, C.-Y. Liu, Q.-H. Sun, M. Sigaud-Fiks, E. Fressinaud, J.-Y. Muller, P. Nurden, A. T. Nurden, P. J. Newman, and N. Valentin
A point mutation in the cysteine-rich domain of glycoprotein (GP) IIIa results in the expression of a GPIIb-IIIa ({alpha}IIb{beta}3) integrin receptor locked in a high-affinity state and a Glanzmann thrombasthenia-like phenotype
Blood, October 15, 2001; 98(8): 2432 - 2441.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Kosugi, Y. Tomiyama, S. Honda, H. Kato, T. Kiyoi, H. Kashiwagi, Y. Kurata, and Y. Matsuzawa
Platelet-associated anti-GPIIb-IIIa autoantibodies in chronic immune thrombocytopenic purpura recognizing epitopes close to the ligand-binding site of glycoprotein (GP) IIb
Blood, September 15, 2001; 98(6): 1819 - 1827.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Lu, M. Ferzly, J. Takagi, and T. A. Springer
Epitope Mapping of Antibodies to the C-Terminal Region of the Integrin {{beta}}2 Subunit Reveals Regions that Become Exposed Upon Receptor Activation
J. Immunol., May 1, 2001; 166(9): 5629 - 5637.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Honda, Y. Tomiyama, N. Pampori, H. Kashiwagi, T. Kiyoi, S. Kosugi, S. Tadokoro, Y. Kurata, S. J. Shattil, and Y. Matsuzawa
Ligand binding to integrin {alpha}v{beta}3 requires tyrosine 178 in the {alpha}v subunit
Blood, January 1, 2001; 97(1): 175 - 182.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Neff, P. W. Mason, and B. Baxt
High-Efficiency Utilization of the Bovine Integrin alpha vbeta 3 as a Receptor for Foot-and-Mouth Disease Virus Is Dependent on the Bovine beta 3 Subunit
J. Virol., August 15, 2000; 74(16): 7298 - 7306.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
Q. Zang and T. A. Springer
Amino Acid Residues in the PSI Domain and Cysteine-rich Repeats of the Integrin beta 2 Subunit That Restrain Activation of the Integrin alpha xbeta 2
J. Biol. Chem., March 2, 2001; 276(10): 6922 - 6929.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Yan and J. W. Smith
A Redox Site Involved in Integrin Activation
J. Biol. Chem., December 15, 2000; 275(51): 39964 - 39972.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1999 by American Society of Hematology         Online ISSN: 1528-0020